We are live on ! Find out more
HA

Homestead Advisers Portfolio holdings

AUM $3.72B
1-Year Est. Return 24.04%
This Fund
S&P 500
This Quarter Est. Return
-1.24%
1 Year Est. Return
+24.04%
3 Year Est. Return
+73.21%
5 Year Est. Return
+100.2%
10 Year Est. Return
+356.14%
AUM
$3.6B
AUM Growth
-$170M
Cap. Flow
-$99.7M
Cap. Flow %
-2.77%
Top 10 Hldgs %
32.74%
Holding
134
New
5
Increased
41
Reduced
21
Closed
3

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$33.3M
2
DIS icon
Walt Disney
DIS
+$11.4M
3
DLR icon
Digital Realty Trust
DLR
+$10.6M
4
GMED icon
Globus Medical
GMED
+$3.7M
5
PH icon
Parker-Hannifin
PH
+$2.33M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.3M
2
GLW icon
Corning
GLW
+$25.1M
3
ABBV icon
AbbVie
ABBV
+$17.8M
4
ABT icon
Abbott
ABT
+$15.9M
5
V icon
Visa
V
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.44%
2 Financials 17.79%
3 Industrials 17.34%
4 Technology 9.99%
5 Energy 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
1
Parker-Hannifin
PH
$125B
$147M 4.07%
376,380
+5,800
+2% +$2.33M
JPM icon
2
JPMorgan Chase
JPM
$939B
$139M 3.85%
955,336
+15,000
+2% +$2.25M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$3.9T
$121M 3.35%
915,460
-94,300
-9% -$12.3M
HON icon
4
Honeywell
HON
$77.1B
$118M 3.28%
677,984
+10,610
+2% +$1.94M
META icon
5
Meta Platforms (Facebook)
META
$1.51T
$115M 3.19%
383,100
-42,600
-10% -$12.8M
ABBV icon
6
AbbVie
ABBV
$458B
$111M 3.09%
745,360
-121,127
-14% -$17.8M
COP icon
7
ConocoPhillips
COP
$147B
$110M 3.05%
917,339
+14,382
+2% +$1.67M
CVX icon
8
Chevron
CVX
$388B
$107M 2.98%
636,612
+9,960
+2% +$1.61M
ABT icon
9
Abbott
ABT
$180B
$107M 2.96%
1,101,146
-151,089
-12% -$15.9M
MSFT icon
10
Microsoft
MSFT
$2.84T
$105M 2.92%
332,687
-118,900
-26% -$39.3M
CB icon
11
Chubb
CB
$140B
$99.2M 2.76%
476,577
+8,400
+2% +$1.7M
GS icon
12
Goldman Sachs
GS
$313B
$95M 2.64%
293,536
+4,300
+1% +$1.44M
V icon
13
Visa
V
$677B
$90.3M 2.51%
392,474
-59,642
-13% -$14.3M
FISV
14
Fiserv Inc
FISV
$27.2B
$87.3M 2.42%
772,900
+12,200
+2% +$1.5M
BSX icon
15
Boston Scientific
BSX
$65.8B
$86.6M 2.41%
1,640,626
+25,200
+2% +$1.32M
CNC icon
16
Centene
CNC
$31.3B
$86M 2.39%
1,249,125
+19,424
+2% +$1.29M
HES
17
DELISTED
Hess
HES
$83.7M 2.33%
547,300
-31,000
-5% -$4.67M
AVY icon
18
Avery Dennison
AVY
$12.3B
$81.8M 2.27%
447,558
-55,300
-11% -$10M
NOC icon
19
Northrop Grumman
NOC
$77B
$79.8M 2.22%
181,272
+2,600
+1% +$1.14M
CSX icon
20
CSX Corp
CSX
$98.6B
$73.8M 2.05%
2,399,536
+37,400
+2% +$1.18M
ETN icon
21
Eaton
ETN
$157B
$73.1M 2.03%
342,604
+5,300
+2% +$1.14M
NXPI icon
22
NXP Semiconductors
NXPI
$68B
$72.6M 2.01%
362,903
+5,700
+2% +$1.18M
FCX icon
23
Freeport-McMoran
FCX
$90B
$70M 1.94%
1,877,903
+29,471
+2% +$1.19M
CI icon
24
Cigna
CI
$76.6B
$69.4M 1.93%
242,762
+3,700
+2% +$1.06M
DE icon
25
Deere & Co
DE
$170B
$69.2M 1.92%
183,422
+2,600
+1% +$1.07M

Similar funds

Homestead Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Homestead Advisers held 134 positions worth $3.6B, down 4.5% from $3.77B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Homestead Advisers's Q3 2023 filing shows 5 new, 41 increased, 21 reduced and 3 closed positions. Its largest new stake was Globus Medical: 66,225 shares worth $3.29M. The largest sale was Microsoft, an estimated $39.3M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

  • Homestead Advisers's largest Q3 2023 buy was Globus Medical: 66,225 shares worth $3.29M.
  • Homestead Advisers added most to Crown Castle in Q3 2023, an estimated $33.3M increase.
  • Homestead Advisers's biggest Q3 2023 reduction was Microsoft, cutting an estimated $39.3M.
  • Homestead Advisers fully exited NuVasive, Inc. in Q3 2023, selling an estimated $3.67M.
  • Homestead Advisers's ten largest holdings make up 33% of its $3.6B portfolio in Q3 2023.
  • Homestead Advisers opened 5 new positions and closed 3 in Q3 2023.
  • Homestead Advisers's portfolio value fell 4.5% quarter-over-quarter to $3.6B.

Based on Homestead Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.